Home / Inspections / 1266574

FDA Inspection 1266574 — PCI Pharma Services Canada, Inc.

PCI Pharma Services Canada, Inc. — FEI 3007309095

The FDA completed an inspection of PCI Pharma Services Canada, Inc. on February 28, 2025 in Mississauga. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Facility

Other inspections at this facility

  • 1091465 (NAI Wed Apr 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 852213 (NAI Wed Sep 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources